Our May Monthly CE event was held on May 17th at the Crest Hollow Country Club. The topic "Entering a New Era of Anticoagulant Reversal Agents" drew a large crowd of attendees.
The Annual Anthony Buatti Pharmacy Resident Research Symposium was held on March 29th. Anthony Buatti was a professor at St. John's University, College of Pharmacy and Health Sciences for over forty years, as well as an active member of LISHP until the time of his passing. Professor Buatti's daughter, Adele McHugh, attended our meeting to … Continue reading The 2016 Anthony Buatti Pharmacy Resident Research Symposium
Dr. Matt Perciavalle, Clinical Pharmacy Specialist of Stony Brook University Hospital's Leukemia, Lymphoma, Transplant (LLT) Service, is one of the fresh new faces of Clinical Pharmacy on Long Island. He has forged a new Pharmacy service in this highly specialized patient population.
We kicked off the new year with a meeting that focused on two very important public health topics: Prevention of Fatal Opioid Overdoses and Hepatitis C infection. We were very pleased to have Dr. Michael Delman, Senior Vice-President Academic Affairs, Southside Hospital as a guest speaker. Dr. Delman trained our members on how to prevent … Continue reading January 2016 Monthly Meeting – Hepatitis C/Opioid Overdose Prevention Program
Medication Safety is a critically-important topic in today's Healthcare environment. Patients are exposed to more complex systems, and with the aging of our population, are more likely to be taking a complex medication regimen. Educated Health-Systems Pharmacists can serve an integral role in improving Medication Safety.
Our first meeting at Cinque Terre Ristorante went great! We hope to have future events at this location due to all of the positive feedback we received! We want to give a warm welcome to our new North Shore members - we hope to see you at more of our meetings coming up soon
LISHP returned from Summer break with a bang! Dr. Daryl Glick from Mount Sinai and Dr. Amy Dzierba from NYP-Columbia engaged in a titanic clash with a critical care debate regarding the use of inhaled nitric oxide vs. aerosolized epoprostenol for acute respiratory distress syndrome.
This is the excerpt for your very first post.